{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:39:47Z","timestamp":1790102387217,"version":"4.0.1"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100003968","name":"Iran National Science Foundation","doi-asserted-by":"publisher","award":["95819873"],"award-info":[{"award-number":["95819873"]}],"id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12943-017-0671-2","type":"journal-article","created":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T12:36:52Z","timestamp":1498048612000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":119,"title":["Dysregulated expression of long noncoding RNAs in gynecologic cancers"],"prefix":"10.1186","volume":"16","author":[{"given":"Elahe Seyed","family":"Hosseini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Meryet-Figuiere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Sabzalipoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed Haddad","family":"Kashani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Nikzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zatollah","family":"Asemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,21]]},"reference":[{"key":"671_CR1","unstructured":"Ferlay J, et al. GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC CancerBase No. 10. Lyon: International Agency for Research on Cancer. 2010;2010:29."},{"issue":"2","key":"671_CR2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1586\/eog.13.5","volume":"8","author":"JK Kalsi","year":"2013","unstructured":"Kalsi JK, Manchanda R, Menon U. Screening for gynecological cancers. Expert Review of Obstetrics & Gynecology. 2013;8(2):143\u201360.","journal-title":"Expert Review of Obstetrics & Gynecology"},{"issue":"4","key":"671_CR3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1525-1438.1997.00462.x","volume":"7","author":"A Hildesheim","year":"1997","unstructured":"Hildesheim A, et al. Sexually transmitted agents and risk of carcinoma of the vagina. Int J Gynecol Cancer. 1997;7(4):251\u20135.","journal-title":"Int J Gynecol Cancer"},{"key":"671_CR4","unstructured":"Shilpa V. Molecular Profiling of Gynaecologic Malignancies: A Review. Hereditary Genetics: Current Research. 2016;2016:1\u20139."},{"issue":"4","key":"671_CR5","first-page":"69","volume":"63","author":"EF Dunne","year":"2014","unstructured":"Dunne EF, et al. CDC grand rounds: reducing the burden of HPV-associated cancer and disease. MMWR Morb Mortal Wkly Rep. 2014;63(4):69\u201372.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"671_CR6","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1016\/S0020-7292(06)60032-5","volume":"95","author":"A Heintz","year":"2006","unstructured":"Heintz A, et al. Carcinoma of the fallopian tube. Int J Gynecol Obstet. 2006;95:S145\u201360.","journal-title":"Int J Gynecol Obstet"},{"issue":"2","key":"671_CR7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","volume":"30","author":"F Medeiros","year":"2006","unstructured":"Medeiros F, et al. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol. 2006;30(2):230\u20136.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"671_CR8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","volume":"34","author":"RJ Kurman","year":"2010","unstructured":"Kurman RJ, Shih I-M. The Origin and pathogenesis of epithelial ovarian cancer-a proposed unifying theory. Am J Surg Pathol. 2010;34(3):433.","journal-title":"Am J Surg Pathol"},{"key":"671_CR9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1177\/107327489900600405","volume":"6","author":"D Cavanagh","year":"1999","unstructured":"Cavanagh D, et al. Adenocarcinoma of the endometrium: an institutional review. Cancer Control. 1999;6:354\u201360.","journal-title":"Cancer Control"},{"issue":"9658","key":"671_CR10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(08)61766-3","volume":"373","author":"H Kitchener","year":"2009","unstructured":"Kitchener H, et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet (London, England). 2009;373(9658):125\u201336.","journal-title":"Lancet (London, England)"},{"issue":"1","key":"671_CR11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nri1260","volume":"4","author":"IH Frazer","year":"2004","unstructured":"Frazer IH. Prevention of cervical cancer through papillomavirus vaccination. Nat Rev Immunol. 2004;4(1):46\u201355.","journal-title":"Nat Rev Immunol"},{"key":"671_CR12","doi-asserted-by":"publisher","unstructured":"Kokka F, et al. Surgical treatment of stage IA2 cervical cancer. Cochrane Database Syst Rev. 2014;(5):CD010870. doi: 10.1002\/14651858.CD010870.pub2 .","DOI":"10.1002\/14651858.CD010870.pub2"},{"issue":"3","key":"671_CR13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.7326\/0003-4819-113-3-214","volume":"113","author":"DM Eddy","year":"1990","unstructured":"Eddy DM. Screening for cervical cancer. Ann Intern Med. 1990;113(3):214\u201326.","journal-title":"Ann Intern Med"},{"issue":"1","key":"671_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-2-35","volume":"2","author":"L Peirson","year":"2013","unstructured":"Peirson L, et al. Screening for cervical cancer: a systematic review and meta-analysis. Systematic reviews. 2013;2(1):1.","journal-title":"Systematic reviews"},{"issue":"1","key":"671_CR15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"671_CR16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal A, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277\u2013300.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"671_CR17","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1002\/cncr.23425","volume":"112","author":"L Huang","year":"2008","unstructured":"Huang L, et al. Improved survival time: What can survival cure models tell us about population-based survival improvements in late-stage colorectal, ovarian, and testicular cancer? Cancer. 2008;112(10):2289\u2013300.","journal-title":"Cancer"},{"issue":"1","key":"671_CR18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s007950300002","volume":"36","author":"T Kaku","year":"2003","unstructured":"Kaku T, et al. Histological classification of ovarian cancer. Medical Electron Microscopy. 2003;36(1):9\u201317.","journal-title":"Medical Electron Microscopy"},{"issue":"3","key":"671_CR19","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1370\/afm.200","volume":"2","author":"UPST Force","year":"2004","unstructured":"Force UPST. Screening for ovarian cancer: recommendation statement. The Annals of Family Medicine. 2004;2(3):260\u20132.","journal-title":"The Annals of Family Medicine"},{"issue":"28","key":"671_CR20","doi-asserted-by":"crossref","first-page":"11667","DOI":"10.1073\/pnas.0904715106","volume":"106","author":"AM Khalil","year":"2009","unstructured":"Khalil AM, et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci. 2009;106(28):11667\u201372.","journal-title":"Proc Natl Acad Sci"},{"issue":"13","key":"671_CR21","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1101\/gad.1800909","volume":"23","author":"JE Wilusz","year":"2009","unstructured":"Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev. 2009;23(13):1494\u2013504.","journal-title":"Genes Dev"},{"issue":"7235","key":"671_CR22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nature07672","volume":"458","author":"M Guttman","year":"2009","unstructured":"Guttman M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. 2009;458(7235):223\u20137.","journal-title":"Nature"},{"issue":"4","key":"671_CR23","doi-asserted-by":"crossref","first-page":"e1000459","DOI":"10.1371\/journal.pgen.1000459","volume":"5","author":"JS Mattick","year":"2009","unstructured":"Mattick JS. The genetic signatures of noncoding RNAs. PLoS Genet. 2009;5(4):e1000459.","journal-title":"PLoS Genet"},{"issue":"4","key":"671_CR24","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.cell.2009.01.035","volume":"136","author":"RW Carthew","year":"2009","unstructured":"Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell. 2009;136(4):642\u201355.","journal-title":"Cell"},{"issue":"12","key":"671_CR25","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/nsmb1167","volume":"13","author":"GM Borchert","year":"2006","unstructured":"Borchert GM, Lanier W, Davidson BL. RNA polymerase III transcribes human microRNAs. Nat Struct Mol Biol. 2006;13(12):1097\u2013101.","journal-title":"Nat Struct Mol Biol"},{"issue":"5","key":"671_CR26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1158\/2159-8290.CD-11-0209","volume":"1","author":"JR Prensner","year":"2011","unstructured":"Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer discovery. 2011;1(5):391\u2013407.","journal-title":"Cancer discovery"},{"issue":"7291","key":"671_CR27","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nature08975","volume":"464","author":"RA Gupta","year":"2010","unstructured":"Gupta RA, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464(7291):1071\u20136.","journal-title":"Nature"},{"issue":"1","key":"671_CR28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ygyno.2014.03.556","volume":"134","author":"J-j Qiu","year":"2014","unstructured":"Qiu J-j, et al. Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer. Gynecol Oncol. 2014;134(1):121\u20138.","journal-title":"Gynecol Oncol"},{"issue":"4","key":"671_CR29","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00404-014-3236-2","volume":"290","author":"L Huang","year":"2014","unstructured":"Huang L, et al. Overexpression of long noncoding RNA HOTAIR predicts a poor prognosis in patients with cervical cancer. Arch Gynecol Obstet. 2014;290(4):717\u201323.","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"671_CR30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3892\/ijmm.2013.1570","volume":"33","author":"X He","year":"2014","unstructured":"He X, et al. The long non-coding RNA HOTAIR is upregulated in endometrial carcinoma and correlates with poor prognosis. Int J Mol Med. 2014;33(2):325\u201332.","journal-title":"Int J Mol Med"},{"issue":"20","key":"671_CR31","doi-asserted-by":"crossref","first-page":"6320","DOI":"10.1158\/0008-5472.CAN-11-1021","volume":"71","author":"R Kogo","year":"2011","unstructured":"Kogo R, et al. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 2011;71(20):6320\u20136.","journal-title":"Cancer Res"},{"issue":"5","key":"671_CR32","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1245\/s10434-011-1581-y","volume":"18","author":"Z Yang","year":"2011","unstructured":"Yang Z, et al. Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol. 2011;18(5):1243\u201350.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"671_CR33","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1158\/0008-5472.CAN-11-1803","volume":"72","author":"T Niinuma","year":"2012","unstructured":"Niinuma T, et al. Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors. Cancer Res. 2012;72(5):1126\u201336.","journal-title":"Cancer Res"},{"issue":"1","key":"671_CR34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3892\/or.2014.3208","volume":"32","author":"X Sheng","year":"2014","unstructured":"Sheng X, et al. Promoter hypermethylation influences the suppressive role of maternally expressed 3, a long non-coding RNA, in the development of epithelial ovarian cancer. Oncol Rep. 2014;32(1):277\u201385.","journal-title":"Oncol Rep"},{"issue":"11","key":"671_CR35","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1210\/jc.2003-030222","volume":"88","author":"X Zhang","year":"2003","unstructured":"Zhang X, et al. A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. The Journal of Clinical Endocrinology & Metabolism. 2003;88(11):5119\u201326.","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"47","key":"671_CR36","doi-asserted-by":"crossref","first-page":"4750","DOI":"10.1038\/onc.2011.193","volume":"30","author":"C Braconi","year":"2011","unstructured":"Braconi C, et al. microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene. 2011;30(47):4750\u20136.","journal-title":"Oncogene"},{"issue":"6","key":"671_CR37","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/jcb.24055","volume":"113","author":"P Wang","year":"2012","unstructured":"Wang P, Ren Z, Sun P. Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation. J Cell Biochem. 2012;113(6):1868\u201374.","journal-title":"J Cell Biochem"},{"issue":"8","key":"671_CR38","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1172\/JCI84421","volume":"126","author":"JR Evans","year":"2016","unstructured":"Evans JR, Feng FY, Chinnaiyan AM. The bright side of dark matter: lncRNAs in cancer. J Clin Investig. 2016;126(8):2775.","journal-title":"J Clin Investig"},{"issue":"1","key":"671_CR39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/carcin\/bgp220","volume":"31","author":"S Sharma","year":"2010","unstructured":"Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis. 2010;31(1):27\u201336.","journal-title":"Carcinogenesis"},{"issue":"11","key":"671_CR40","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJMra072067","volume":"358","author":"M Esteller","year":"2008","unstructured":"Esteller M. Epigenetics in cancer. N Engl J Med. 2008;358(11):1148\u201359.","journal-title":"N Engl J Med"},{"issue":"6113","key":"671_CR41","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1126\/science.1231776","volume":"338","author":"JT Lee","year":"2012","unstructured":"Lee JT. Epigenetic regulation by long noncoding RNAs. Science. 2012;338(6113):1435\u20139.","journal-title":"Science"},{"issue":"12","key":"671_CR42","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nrg3603","volume":"14","author":"YB Schwartz","year":"2013","unstructured":"Schwartz YB, Pirrotta V. A new world of Polycombs: unexpected partnerships and emerging functions. Nat Rev Genet. 2013;14(12):853\u201364.","journal-title":"Nat Rev Genet"},{"issue":"20","key":"671_CR43","doi-asserted-by":"crossref","first-page":"11606","DOI":"10.1073\/pnas.1933744100","volume":"100","author":"CG Kleer","year":"2003","unstructured":"Kleer CG, et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci. 2003;100(20):11606\u201311.","journal-title":"Proc Natl Acad Sci"},{"issue":"6907","key":"671_CR44","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nature01075","volume":"419","author":"S Varambally","year":"2002","unstructured":"Varambally S, et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature. 2002;419(6907):624\u20139.","journal-title":"Nature"},{"issue":"3","key":"671_CR45","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ccr.2014.07.009","volume":"26","author":"X Hu","year":"2014","unstructured":"Hu X, et al. A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer. Cancer Cell. 2014;26(3):344\u201357.","journal-title":"Cancer Cell"},{"issue":"11","key":"671_CR46","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/nsmb.2679","volume":"20","author":"C Davidovich","year":"2013","unstructured":"Davidovich C, et al. Promiscuous RNA binding by Polycomb repressive complex 2. Nat Struct Mol Biol. 2013;20(11):1250\u20137.","journal-title":"Nat Struct Mol Biol"},{"issue":"7","key":"671_CR47","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.cell.2007.05.022","volume":"129","author":"JL Rinn","year":"2007","unstructured":"Rinn JL, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell. 2007;129(7):1311\u201323.","journal-title":"Cell"},{"key":"671_CR48","doi-asserted-by":"crossref","unstructured":"Mondal T, et al. MEG3 long noncoding RNA regulates the TGF-[beta] pathway genes through formation of RNA-DNA triplex structures. Nat Commun. 2015;6:7743\u201360.","DOI":"10.1038\/ncomms8743"},{"issue":"3","key":"671_CR49","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.molcel.2014.12.017","volume":"57","author":"C Davidovich","year":"2015","unstructured":"Davidovich C, et al. Toward a consensus on the binding specificity and promiscuity of PRC2 for RNA. Mol Cell. 2015;57(3):552\u20138.","journal-title":"Mol Cell"},{"issue":"8","key":"671_CR50","doi-asserted-by":"crossref","first-page":"979","DOI":"10.4161\/rna.29937","volume":"11","author":"Z Li","year":"2014","unstructured":"Li Z, Rana TM. Decoding the noncoding: prospective of lncRNA-mediated innate immune regulation. RNA Biol. 2014;11(8):979\u201385.","journal-title":"RNA Biol"},{"issue":"5","key":"671_CR51","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.drudis.2012.10.002","volume":"18","author":"DM Pereira","year":"2013","unstructured":"Pereira DM, et al. Delivering the promise of miRNA cancer therapeutics. Drug Discov Today. 2013;18(5):282\u20139.","journal-title":"Drug Discov Today"},{"issue":"6","key":"671_CR52","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/15476286.2015.1034912","volume":"12","author":"J McCaskill","year":"2015","unstructured":"McCaskill J, et al. RNA-mediated degradation of microRNAs: A widespread viral strategy? RNA Biol. 2015;12(6):579\u201385.","journal-title":"RNA Biol"},{"issue":"30","key":"671_CR53","doi-asserted-by":"crossref","first-page":"29209","DOI":"10.18632\/oncotarget.4976","volume":"6","author":"C Vennin","year":"2015","unstructured":"Vennin C, et al. H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b. Oncotarget. 2015;6(30):29209\u201323.","journal-title":"Oncotarget"},{"issue":"34","key":"671_CR54","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.2174\/1381612821666150724115625","volume":"21","author":"Y Wu","year":"2015","unstructured":"Wu Y, et al. Long noncoding RNA MALAT1: insights into its biogenesis and implications in human disease. Curr Pharm Des. 2015;21(34):5017\u201328.","journal-title":"Curr Pharm Des"},{"issue":"1","key":"671_CR55","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bbagrm.2015.09.012","volume":"1859","author":"R Yoshimoto","year":"2016","unstructured":"Yoshimoto R, et al. MALAT1 long non-coding RNA in cancer. Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms. 2016;1859(1):192\u20139.","journal-title":"Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms"},{"issue":"39","key":"671_CR56","doi-asserted-by":"crossref","first-page":"8031","DOI":"10.1038\/sj.onc.1206928","volume":"22","author":"P Ji","year":"2003","unstructured":"Ji P, et al. MALAT-1, a novel noncoding RNA, and thymosin \u03b24 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene. 2003;22(39):8031\u201341.","journal-title":"Oncogene"},{"issue":"4","key":"671_CR57","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.febslet.2011.01.030","volume":"585","author":"R Lin","year":"2011","unstructured":"Lin R, et al. Control of RNA processing by a large non-coding RNA over-expressed in carcinomas. FEBS Lett. 2011;585(4):671\u20136.","journal-title":"FEBS Lett"},{"issue":"7","key":"671_CR58","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00109-013-1028-y","volume":"91","author":"T Gutschner","year":"2013","unstructured":"Gutschner T, H\u00e4mmerle M, Diederichs S. MALAT1\u2014a paradigm for long noncoding RNA function in cancer. J Mol Med. 2013;91(7):791\u2013801.","journal-title":"J Mol Med"},{"issue":"1","key":"671_CR59","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.canlet.2016.09.019","volume":"383","author":"Q Li","year":"2016","unstructured":"Li Q, et al. Disrupting MALAT1\/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma. Cancer Lett. 2016;383(1):28\u201340.","journal-title":"Cancer Lett"},{"issue":"18","key":"671_CR60","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1158\/0008-5472.CAN-14-0427","volume":"74","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, et al. A novel wnt regulatory axis in endometrioid endometrial cancer. Cancer Res. 2014;74(18):5103\u201317.","journal-title":"Cancer Res"},{"issue":"7","key":"671_CR61","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/sj.onc.1209154","volume":"25","author":"J Ying","year":"2006","unstructured":"Ying J, et al. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation. Oncogene. 2006;25(7):1070\u201380.","journal-title":"Oncogene"},{"issue":"3","key":"671_CR62","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00432-012-1353-5","volume":"139","author":"X Zhong","year":"2013","unstructured":"Zhong X, et al. Frequent epigenetic silencing of PCDH10 by methylation in human colorectal cancer. J Cancer Res Clin Oncol. 2013;139(3):485\u201390.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"11","key":"671_CR63","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/gcc.20703","volume":"48","author":"G Narayan","year":"2009","unstructured":"Narayan G, et al. Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer. Genes Chromosom Cancer. 2009;48(11):983\u201392.","journal-title":"Genes Chromosom Cancer"},{"issue":"3","key":"671_CR64","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1007\/s12032-011-0004-z","volume":"29","author":"M-c Lai","year":"2012","unstructured":"Lai M-c, et al. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol. 2012;29(3):1810\u20136.","journal-title":"Med Oncol"},{"issue":"7","key":"671_CR65","doi-asserted-by":"crossref","first-page":"e0131699","DOI":"10.1371\/journal.pone.0131699","volume":"10","author":"I F\u0171ri","year":"2015","unstructured":"F\u0171ri I, et al. Cell Free DNA of Tumor Origin Induces a \u2018Metastatic\u2019Expression Profile in HT-29 Cancer Cell Line. PLoS One. 2015;10(7):e0131699.","journal-title":"PLoS One"},{"issue":"6","key":"671_CR66","doi-asserted-by":"crossref","first-page":"806","DOI":"10.4161\/cbt.28584","volume":"15","author":"X-S Wu","year":"2014","unstructured":"Wu X-S, et al. MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK\/MAPK pathway. Cancer biology & therapy. 2014;15(6):806\u201314.","journal-title":"Cancer biology & therapy"},{"issue":"9","key":"671_CR67","doi-asserted-by":"crossref","first-page":"e0163460","DOI":"10.1371\/journal.pone.0163460","volume":"11","author":"S Liu","year":"2016","unstructured":"Liu S, et al. MiR-375 Is Epigenetically Downregulated by HPV-16 E6 Mediated DNMT1 Upregulation and Modulates EMT of Cervical Cancer Cells by Suppressing lncRNA MALAT1. PLoS One. 2016;11(9):e0163460.","journal-title":"PLoS One"},{"issue":"17","key":"671_CR68","first-page":"3187","volume":"19","author":"L Yang","year":"2015","unstructured":"Yang L, et al. High MALAT1 expression predicts a poor prognosis of cervical cancer and promotes cancer cell growth and invasion. Eur Rev Med Pharmacol Sci. 2015;19(17):3187\u201393.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"671_CR69","first-page":"1497","volume":"20","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, et al. Human MALAT-1 long non-coding RNA is overexpressed in cervical cancer metastasis and promotes cell proliferation, invasion and migration. Journal of BU ON: official journal of the Balkan Union of Oncology. 2015;20(6):1497.","journal-title":"Journal of BU ON: official journal of the Balkan Union of Oncology"},{"issue":"3","key":"671_CR70","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/abbs\/gmq008","volume":"42","author":"F Guo","year":"2010","unstructured":"Guo F, et al. Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion. Acta Biochim Biophys Sin. 2010;42(3):224\u20139.","journal-title":"Acta Biochim Biophys Sin"},{"issue":"3","key":"671_CR71","first-page":"138","volume":"10","author":"S-P Liu","year":"2013","unstructured":"Liu S-P, et al. Identification of differentially expressed long non-coding RNAs in human ovarian cancer cells with different metastatic potentials. Cancer biology & medicine. 2013;10(3):138\u201341.","journal-title":"Cancer biology & medicine"},{"issue":"6","key":"671_CR72","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.3892\/ol.2016.4435","volume":"11","author":"S Liu","year":"2016","unstructured":"Liu S, et al. Inhibition of the long non-coding RNA MALAT1 suppresses tumorigenicity and induces apoptosis in the human ovarian cancer SKOV3 cell line. Oncol Lett. 2016;11(6):3686\u201392.","journal-title":"Oncol Lett"},{"issue":"5","key":"671_CR73","doi-asserted-by":"crossref","first-page":"582","DOI":"10.4161\/rna.7.5.13216","volume":"7","author":"T Hung","year":"2010","unstructured":"Hung T, Chang HY. Long noncoding RNA in genome regulation: prospects and mechanisms. RNA Biol. 2010;7(5):582\u20135.","journal-title":"RNA Biol"},{"issue":"4","key":"671_CR74","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/cas.12092","volume":"104","author":"Y Nie","year":"2013","unstructured":"Nie Y, et al. Long non-coding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progression and survival. Cancer Sci. 2013;104(4):458\u201364.","journal-title":"Cancer Sci"},{"issue":"19","key":"671_CR75","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1016\/j.jmb.2013.01.022","volume":"425","author":"A Bhan","year":"2013","unstructured":"Bhan A, et al. Antisense transcript long noncoding RNA (lncRNA) HOTAIR is transcriptionally induced by estradiol. J Mol Biol. 2013;425(19):3707\u201322.","journal-title":"J Mol Biol"},{"issue":"4","key":"671_CR76","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/IGC.0000000000000121","volume":"24","author":"J Huang","year":"2014","unstructured":"Huang J, et al. Lentivirus-mediated RNA interference targeting the long noncoding RNA HOTAIR inhibits proliferation and invasion of endometrial carcinoma cells in vitro and in vivo. Int J Gynecol Cancer. 2014;24(4):635\u201342.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"671_CR77","first-page":"1","volume":"12","author":"M Hajjari","year":"2015","unstructured":"Hajjari M, Salavaty A. HOTAIR: an oncogenic long non-coding RNA in different cancers. Cancer biology & medicine. 2015;12(1):1\u20139.","journal-title":"Cancer biology & medicine"},{"issue":"2","key":"671_CR78","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.yexcr.2015.03.005","volume":"333","author":"J-j Qiu","year":"2015","unstructured":"Qiu J-j, et al. The long non-coding RNA HOTAIR promotes the proliferation of serous ovarian cancer cells through the regulation of cell cycle arrest and apoptosis. Exp Cell Res. 2015;333(2):238\u201348.","journal-title":"Exp Cell Res"},{"issue":"2","key":"671_CR79","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s13277-015-3998-6","volume":"37","author":"J Li","year":"2016","unstructured":"Li J, et al. Overexpression of long non-coding RNA HOTAIR leads to chemoresistance by activating the Wnt\/\u03b2-catenin pathway in human ovarian cancer. Tumor Biol. 2016;37(2):2057\u201365.","journal-title":"Tumor Biol"},{"issue":"2","key":"671_CR80","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3892\/ijo.2014.2758","volume":"46","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, et al. Long non-coding RNA HOTAIR is associated with human cervical cancer progression. Int J Oncol. 2015;46(2):521\u201330.","journal-title":"Int J Oncol"},{"key":"671_CR81","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ygyno.2014.03.027","volume":"133","author":"HJ Kim","year":"2014","unstructured":"Kim HJ, et al. Long noncoding RNA HOTAIR is associated with human cervical cancer progression. Gynecol Oncol. 2014;133:5.","journal-title":"Gynecol Oncol"},{"issue":"8","key":"671_CR82","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/ng.168","volume":"40","author":"G Smits","year":"2008","unstructured":"Smits G, et al. Conservation of the H19 noncoding RNA and H19-IGF2 imprinting mechanism in therians. Nat Genet. 2008;40(8):971\u20136.","journal-title":"Nat Genet"},{"key":"671_CR83","doi-asserted-by":"crossref","unstructured":"Jing W, et al. The Significance of Long Noncoding RNA H19 in Predicting Progression and Metastasis of Cancers: A Meta-Analysis. Biomed Res Int. 2016;2016","DOI":"10.1155\/2016\/5902678"},{"issue":"1","key":"671_CR84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-015-0458-2","volume":"14","author":"E Raveh","year":"2015","unstructured":"Raveh E, et al. The H19 Long non-coding RNA in cancer initiation, progression and metastasis\u2013a proposed unifying theory. Mol Cancer. 2015;14(1):1.","journal-title":"Mol Cancer"},{"issue":"1","key":"671_CR85","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1152\/physiolgenomics.00291.2005","volume":"29","author":"M Ivanga","year":"2007","unstructured":"Ivanga M, et al. Temporal analysis of E2 transcriptional induction of PTP and MKP and downregulation of IGF-I pathway key components in the mouse uterus. Physiol Genomics. 2007;29(1):13\u201323.","journal-title":"Physiol Genomics"},{"issue":"2","key":"671_CR86","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/mc.10075","volume":"35","author":"S Ayesh","year":"2002","unstructured":"Ayesh S, et al. Possible physiological role of H19 RNA. Mol Carcinog. 2002;35(2):63\u201374.","journal-title":"Mol Carcinog"},{"issue":"4","key":"671_CR87","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1242\/jcs.114.4.825","volume":"114","author":"ME Kroon","year":"2001","unstructured":"Kroon ME, et al. Hypoxia in combination with FGF-2 induces tube formation by human microvascular endothelial cells in a fibrin matrix: involvement of at least two signal transduction pathways. J Cell Sci. 2001;114(4):825\u201333.","journal-title":"J Cell Sci"},{"issue":"14","key":"671_CR88","doi-asserted-by":"crossref","first-page":"8064","DOI":"10.1073\/pnas.95.14.8064","volume":"95","author":"C Tselepis","year":"1998","unstructured":"Tselepis C, et al. Desmosomal adhesion inhibits invasive behavior. Proc Natl Acad Sci. 1998;95(14):8064\u20139.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"671_CR89","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0301-2115(98)00275-9","volume":"85","author":"V Tanos","year":"1999","unstructured":"Tanos V, et al. Expression of the imprinted H19 oncofetal RNA in epithelial ovarian cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology. 1999;85(1):7\u201311.","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"issue":"7","key":"671_CR90","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.bbamcr.2014.03.023","volume":"1843","author":"IJ Matouk","year":"2014","unstructured":"Matouk IJ, et al. Oncofetal H19 RNA promotes tumor metastasis. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research. 2014;1843(7):1414\u201326.","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Cell Research"},{"key":"671_CR91","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3389\/fonc.2014.00144","volume":"4","author":"DJ Marsh","year":"2014","unstructured":"Marsh DJ, Shah JS, Cole AJ. Histones and their modifications in ovarian cancer\u2013drivers of disease and therapeutic targets. Front Oncol. 2014;4:144.","journal-title":"Front Oncol"},{"issue":"4","key":"671_CR92","doi-asserted-by":"crossref","first-page":"314","DOI":"10.4143\/crt.2003.35.4.314","volume":"35","author":"C Lee","year":"2003","unstructured":"Lee C, et al. Alterations in Promoter Usage and Expression Levels of Insulin-like Growth Factor-II and H19 Genes in Cervical and Endometrial Cancer. Cancer Res Treat. 2003;35(4):314\u201322.","journal-title":"Cancer Res Treat"},{"issue":"2","key":"671_CR93","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/(SICI)1097-0177(199806)212:2<214::AID-AJA6>3.0.CO;2-K","volume":"212","author":"K Schuster-Gossler","year":"1998","unstructured":"Schuster-Gossler K, et al. The mouseGtl 2 gene is differentially expressed during embryonic development, encodes multiple alternatively spliced transcripts, and may act as an RNA. Dev Dyn. 1998;212(2):214\u201328.","journal-title":"Dev Dyn"},{"issue":"1","key":"671_CR94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-016-0530-6","volume":"15","author":"N Bartonicek","year":"2016","unstructured":"Bartonicek N, Maag JL, Dinger ME. Long noncoding RNAs in cancer: mechanisms of action and technological advancements. Mol Cancer. 2016;15(1):1.","journal-title":"Mol Cancer"},{"issue":"4","key":"671_CR95","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/ijc.26052","volume":"129","author":"L Benetatos","year":"2011","unstructured":"Benetatos L, Vartholomatos G, Hatzimichael E. MEG3 imprinted gene contribution in tumorigenesis. Int J Cancer. 2011;129(4):773\u20139.","journal-title":"Int J Cancer"},{"issue":"1","key":"671_CR96","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mce.2010.02.040","volume":"326","author":"X Zhang","year":"2010","unstructured":"Zhang X, Zhou Y, Klibanski A. Isolation and characterization of novel pituitary tumor related genes: a cDNA representational difference approach. Mol Cell Endocrinol. 2010;326(1):40\u20137.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"671_CR97","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/15384047.2015.1108496","volume":"17","author":"J Zhang","year":"2016","unstructured":"Zhang J, et al. Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21. Cancer biology & therapy. 2016;17(1):104\u201313.","journal-title":"Cancer biology & therapy"},{"issue":"1","key":"671_CR98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13000-016-0499-x","volume":"11","author":"S Huang","year":"2016","unstructured":"Huang S, et al. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis. Diagn Pathol. 2016;11(1):1.","journal-title":"Diagn Pathol"},{"key":"671_CR99","doi-asserted-by":"crossref","first-page":"875","DOI":"10.12659\/MSM.897754","volume":"22","author":"LJ Wu Le","year":"2016","unstructured":"Le Wu LJ, Zhang W, Zhang L. Roles of Long Non-Coding RNA CCAT2 in Cervical Cancer Cell Growth and Apoptosis. Med Sci Monit. 2016;22:875.","journal-title":"Med Sci Monit"},{"issue":"1","key":"671_CR100","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.3390\/ijms14011278","volume":"14","author":"A Congrains","year":"2013","unstructured":"Congrains A, et al. ANRIL: molecular mechanisms and implications in human health. Int J Mol Sci. 2013;14(1):1278\u201392.","journal-title":"Int J Mol Sci"},{"key":"671_CR101","doi-asserted-by":"crossref","unstructured":"Meryet-Figui\u00e8re M, et al. An overview of long non-coding RNAs in ovarian cancers. Oncotarget. 2016;7(28):44719\u201334.","DOI":"10.18632\/oncotarget.8089"},{"issue":"22","key":"671_CR102","doi-asserted-by":"crossref","first-page":"32478","DOI":"10.18632\/oncotarget.8744","volume":"7","author":"J-j Qiu","year":"2016","unstructured":"Qiu J-j, et al. The long non-coding RNA ANRIL promotes proliferation and cell cycle progression and inhibits apoptosis and senescence in epithelial ovarian cancer. Oncotarget. 2016;7(22):32478.","journal-title":"Oncotarget"},{"key":"671_CR103","doi-asserted-by":"crossref","unstructured":"Qiu J, et al. The long non-coding RNA ANRIL promotes proliferation and cell cycle progression and inhibits apoptosis and senescence in epithelial ovarian cancer. Oncotarget. 2016;7(22):32478\u201392.","DOI":"10.18632\/oncotarget.8744"},{"issue":"10","key":"671_CR104","first-page":"5377","volume":"35","author":"M Naemura","year":"2015","unstructured":"Naemura M, et al. Long noncoding RNA ANRIL regulates proliferation of non-small cell lung cancer and cervical cancer cells. Anticancer Res. 2015;35(10):5377\u201382.","journal-title":"Anticancer Res"},{"issue":"11","key":"671_CR105","doi-asserted-by":"crossref","first-page":"e80306","DOI":"10.1371\/journal.pone.0080306","volume":"8","author":"R Akrami","year":"2013","unstructured":"Akrami R, et al. Comprehensive analysis of long non-coding RNAs in ovarian cancer reveals global patterns and targeted DNA amplification. PLoS One. 2013;8(11):e80306.","journal-title":"PLoS One"},{"issue":"11","key":"671_CR106","doi-asserted-by":"crossref","first-page":"26463","DOI":"10.3390\/ijms161125962","volume":"16","author":"MA Smolle","year":"2015","unstructured":"Smolle MA, et al. Long Non-Coding RNAs in Endometrial Carcinoma. Int J Mol Sci. 2015;16(11):26463\u201372.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"671_CR107","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00432-015-2042-y","volume":"142","author":"M Xue","year":"2016","unstructured":"Xue M, Chen W, Li X. Urothelial cancer associated 1: a long noncoding RNA with a crucial role in cancer. J Cancer Res Clin Oncol. 2016;142(7):1407\u201319.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"16","key":"671_CR108","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1158\/1078-0432.CCR-06-0134","volume":"12","author":"X-S Wang","year":"2006","unstructured":"Wang X-S, et al. Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma. Clin Cancer Res. 2006;12(16):4851\u20138.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"671_CR109","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1261\/rna.359007","volume":"13","author":"WP Tsang","year":"2007","unstructured":"Tsang WP, et al. Induction of drug resistance and transformation in human cancer cells by the noncoding RNA CUDR. RNA. 2007;13(6):890\u20138.","journal-title":"RNA"},{"issue":"3","key":"671_CR110","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00280-016-2963-4","volume":"77","author":"L Zhang","year":"2016","unstructured":"Zhang L, et al. UCA1 overexpression predicts clinical outcome of patients with ovarian cancer receiving adjuvant chemotherapy. Cancer Chemother Pharmacol. 2016;77(3):629\u201334.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"671_CR111","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/cbr.2016.2156","volume":"32","author":"B Wang","year":"2017","unstructured":"Wang B, et al. Expression of Long Noncoding RNA Urothelial Cancer Associated 1 Promotes Cisplatin Resistance in Cervical Cancer. Cancer Biother Radiopharm. 2017;32(3):101\u201310.","journal-title":"Cancer Biother Radiopharm"},{"issue":"20","key":"671_CR112","doi-asserted-by":"crossref","first-page":"7163","DOI":"10.1128\/MCB.23.20.7163-7176.2003","volume":"23","author":"RB Lanz","year":"2003","unstructured":"Lanz RB, et al. Steroid receptor RNA activator stimulates proliferation as well as apoptosis in vivo. Mol Cell Biol. 2003;23(20):7163\u201376.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"671_CR113","doi-asserted-by":"crossref","first-page":"e977154","DOI":"10.4161\/23723556.2014.977154","volume":"2","author":"X Zhong","year":"2015","unstructured":"Zhong X, Hu X, Zhang L. Oncogenic long noncoding RNA FAL1 in human cancer. Molecular & Cellular Oncology. 2015;2(2):e977154.","journal-title":"Molecular & Cellular Oncology"},{"issue":"2","key":"671_CR114","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.trecan.2015.08.010","volume":"1","author":"A Sahu","year":"2015","unstructured":"Sahu A, Singhal U, Chinnaiyan AM. Long noncoding RNAs in cancer: from function to translation. Trends in cancer. 2015;1(2):93\u2013109.","journal-title":"Trends in cancer"},{"issue":"28","key":"671_CR115","doi-asserted-by":"crossref","first-page":"25381","DOI":"10.18632\/oncotarget.4541","volume":"6","author":"Z Cheng","year":"2015","unstructured":"Cheng Z, et al. A long noncoding RNA AB073614 promotes tumorigenesis and predicts poor prognosis in ovarian cancer. Oncotarget. 2015;6(28):25381.","journal-title":"Oncotarget"},{"issue":"3","key":"671_CR116","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/hmg\/ddu502","volume":"24","author":"Y Gao","year":"2015","unstructured":"Gao Y, et al. LncRNA-HOST2 regulates cell biological behaviors in epithelial ovarian cancer through a mechanism involving microRNA let-7b. Hum Mol Genet. 2015;24(3):841\u201352.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"671_CR117","doi-asserted-by":"crossref","first-page":"496","DOI":"10.4161\/rna.8.3.14800","volume":"8","author":"JM Silva","year":"2011","unstructured":"Silva JM, et al. LSINCT5 is over expressed in breast and ovarian cancer and affects cellular proliferation. RNA Biol. 2011;8(3):496\u2013505.","journal-title":"RNA Biol"},{"issue":"19","key":"671_CR118","doi-asserted-by":"crossref","first-page":"5745","DOI":"10.1158\/1078-0432.CCR-06-2882","volume":"13","author":"Y Guan","year":"2007","unstructured":"Guan Y, et al. Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin Cancer Res. 2007;13(19):5745\u201355.","journal-title":"Clin Cancer Res"},{"key":"671_CR119","doi-asserted-by":"crossref","unstructured":"Tseng Y-Y, et al. PVT1 dependence in cancer with MYC copy-number increase. Nature. 2014;512(7512):82\u20136.","DOI":"10.1038\/nature13311"},{"issue":"33","key":"671_CR120","doi-asserted-by":"crossref","first-page":"34745","DOI":"10.18632\/oncotarget.5784","volume":"6","author":"EJ Richards","year":"2015","unstructured":"Richards EJ, et al. A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer. Oncotarget. 2015;6(33):34745.","journal-title":"Oncotarget"},{"issue":"2","key":"671_CR121","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3892\/ol.2015.3983","volume":"11","author":"D Wu","year":"2016","unstructured":"Wu D, et al. Downregulation of BC200 in ovarian cancer contributes to cancer cell proliferation and chemoresistance to carboplatin. Oncol Lett. 2016;11(2):1189\u201394.","journal-title":"Oncol Lett"},{"issue":"7","key":"671_CR122","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/IGC.0000000000000212","volume":"24","author":"M Zhao","year":"2014","unstructured":"Zhao M, et al. long non-coding RNAs involved in gynecological cancer. Int J Gynecol Cancer. 2014;24(7):1140\u20135.","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"671_CR123","doi-asserted-by":"crossref","first-page":"e100340","DOI":"10.1371\/journal.pone.0100340","volume":"9","author":"N-x Sun","year":"2014","unstructured":"Sun N-x, et al. Long noncoding RNA-EBIC promotes tumor cell invasion by binding to EZH2 and repressing E-cadherin in cervical cancer. PLoS One. 2014;9(7):e100340.","journal-title":"PLoS One"},{"issue":"6","key":"671_CR124","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0092-8674(88)91065-3","volume":"54","author":"C Schneider","year":"1988","unstructured":"Schneider C, King RM, Philipson L. Genes specifically expressed at growth arrest of mammalian cells. Cell. 1988;54(6):787\u201393.","journal-title":"Cell"},{"issue":"3","key":"671_CR125","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3390\/genes6030484","volume":"6","author":"MR Pickard","year":"2015","unstructured":"Pickard MR, Williams GT. Molecular and cellular mechanisms of action of tumour suppressor GAS5 LncRNA. Genes. 2015;6(3):484\u201399.","journal-title":"Genes"},{"issue":"9","key":"671_CR126","doi-asserted-by":"crossref","first-page":"10104","DOI":"10.18632\/oncotarget.7173","volume":"7","author":"MR Pickard","year":"2016","unstructured":"Pickard MR, Williams GT. The hormone response element mimic sequence of GAS5 lncRNA is sufficient to induce apoptosis in breast cancer cells. Oncotarget. 2016;7(9):10104.","journal-title":"Oncotarget"},{"issue":"10","key":"671_CR127","first-page":"6776","volume":"7","author":"S Cao","year":"2014","unstructured":"Cao S, et al. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer. Int J Clin Exp Pathol. 2014;7(10):6776\u201383.","journal-title":"Int J Clin Exp Pathol"},{"issue":"10","key":"671_CR128","doi-asserted-by":"crossref","first-page":"7615","DOI":"10.1007\/s13277-015-3465-4","volume":"36","author":"M Yang","year":"2015","unstructured":"Yang M, et al. Long noncoding RNA CCHE1 promotes cervical cancer cell proliferation via upregulating PCNA. Tumor Biol. 2015;36(10):7615\u201322.","journal-title":"Tumor Biol"},{"issue":"1","key":"671_CR129","first-page":"806","volume":"8","author":"S Jiang","year":"2015","unstructured":"Jiang S, Wang H-L, Yang J. Low expression of long non-coding RNA LET inhibits carcinogenesis of cervical cancer. Int J Clin Exp Pathol. 2015;8(1):806\u201311.","journal-title":"Int J Clin Exp Pathol"},{"issue":"20","key":"671_CR130","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1200\/JCO.2007.11.0932","volume":"25","author":"AN Fader","year":"2007","unstructured":"Fader AN, Rose PG. Role of surgery in ovarian carcinoma. J Clin Oncol. 2007;25(20):2873\u201383.","journal-title":"J Clin Oncol"},{"issue":"2","key":"671_CR131","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69\u201390.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"671_CR132","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrclinonc.2013.5","volume":"10","author":"RL Coleman","year":"2013","unstructured":"Coleman RL, et al. Latest research and treatment of advanced-stage epithelial ovarian cancer. Nat Rev Clin Oncol. 2013;10(4):211\u201324.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"671_CR133","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s13277-015-3732-4","volume":"37","author":"S Liu","year":"2016","unstructured":"Liu S, et al. MALAT1-miR-124-RBG2 axis is involved in growth and invasion of HR-HPV-positive cervical cancer cells. Tumor Biol. 2016;37(1):633\u201340.","journal-title":"Tumor Biol"},{"issue":"2","key":"671_CR134","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s13277-015-3946-5","volume":"37","author":"H Lu","year":"2016","unstructured":"Lu H, et al. Long non-coding RNA MALAT1 modulates radiosensitivity of HR-HPV+ cervical cancer via sponging miR-145. Tumor Biol. 2016;37(2):1683\u201391.","journal-title":"Tumor Biol"},{"issue":"3","key":"671_CR135","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ygyno.2014.03.555","volume":"133","author":"L-M Liao","year":"2014","unstructured":"Liao L-M, et al. Low expression of long noncoding XLOC_010588 indicates a poor prognosis and promotes proliferation through upregulation of c-Myc in cervical cancer. Gynecol Oncol. 2014;133(3):616\u201323.","journal-title":"Gynecol Oncol"},{"issue":"10","key":"671_CR136","doi-asserted-by":"crossref","first-page":"9531","DOI":"10.1007\/s13277-014-2523-7","volume":"35","author":"Y Wu","year":"2014","unstructured":"Wu Y, et al. Long noncoding RNA HOTAIR involvement in cancer. Tumor Biol. 2014;35(10):9531\u20138.","journal-title":"Tumor Biol"},{"issue":"1","key":"671_CR137","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00019606-199702000-00004","volume":"6","author":"I Ariel","year":"1997","unstructured":"Ariel I, et al. Genomic Imprinting and the Endometrial Cycle: The Expression of the Imprinted Gene H19 in the Human Female Reproductive Organs. Diagn Mol Pathol. 1997;6(1):17\u201325.","journal-title":"Diagn Mol Pathol"},{"issue":"3","key":"671_CR138","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1048-891x.2004.014314.x","volume":"14","author":"V Tanos","year":"2004","unstructured":"Tanos V, et al. H19 and IGF2 gene expression in human normal, hyperplastic, and malignant endometrium. Int J Gynecol Cancer. 2004;14(3):521\u20135.","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"671_CR139","doi-asserted-by":"crossref","first-page":"996","DOI":"10.15252\/emmm.201505245","volume":"7","author":"S Ghazal","year":"2015","unstructured":"Ghazal S, et al. H19 lncRNA alters stromal cell growth via IGF signaling in the endometrium of women with endometriosis. EMBO molecular medicine. 2015;7(8):996\u20131003.","journal-title":"EMBO molecular medicine"},{"issue":"2","key":"671_CR140","first-page":"423","volume":"12","author":"S Douc-Rasy","year":"1996","unstructured":"Douc-Rasy S, et al. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19. Oncogene. 1996;12(2):423\u201330.","journal-title":"Oncogene"},{"issue":"23","key":"671_CR141","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1038\/onc.2014.236","volume":"34","author":"L Yan","year":"2015","unstructured":"Yan L, et al. Regulation of tumor cell migration and invasion by the H19\/let-7 axis is antagonized by metformin-induced DNA methylation. Oncogene. 2015;34(23):3076\u201384.","journal-title":"Oncogene"},{"issue":"5","key":"671_CR142","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4149\/neo_2013_063","volume":"60","author":"R Qin","year":"2012","unstructured":"Qin R, et al. Long non-coding RNA MEG3 inhibits the proliferation of cervical carcinoma cells through the induction of cell cycle arrest and apoptosis. Neoplasma. 2012;60(5):486\u201392.","journal-title":"Neoplasma"},{"issue":"10","key":"671_CR143","first-page":"13261","volume":"8","author":"X Chen","year":"2015","unstructured":"Chen X, Liu L, Zhu W. Up-regulation of long non-coding RNA CCAT2 correlates with tumor metastasis and poor prognosis in cervical squamous cell cancer patients. Int J Clin Exp Pathol. 2015;8(10):13261.","journal-title":"Int J Clin Exp Pathol"},{"issue":"6","key":"671_CR144","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.3892\/ijo.2015.2943","volume":"46","author":"J-J Qiu","year":"2015","unstructured":"Qiu J-J, et al. Long non-coding RNA ANRIL predicts poor prognosis and promotes invasion\/metastasis in serous ovarian cancer. Int J Oncol. 2015;46(6):2497\u2013505.","journal-title":"Int J Oncol"},{"issue":"1","key":"671_CR145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13073-015-0233-4","volume":"7","author":"AE Teschendorff","year":"2015","unstructured":"Teschendorff AE, et al. HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer. Genome medicine. 2015;7(1):1.","journal-title":"Genome medicine"},{"issue":"3","key":"671_CR146","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1039\/C4MB00511B","volume":"11","author":"M Zhou","year":"2015","unstructured":"Zhou M, et al. Prioritizing candidate disease-related long non-coding RNAs by walking on the heterogeneous lncRNA and disease network. Mol BioSyst. 2015;11(3):760\u20139.","journal-title":"Mol BioSyst"},{"issue":"10a","key":"671_CR147","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1101\/gr.2722704","volume":"14","author":"A Rodriguez","year":"2004","unstructured":"Rodriguez A, et al. Identification of mammalian microRNA host genes and transcription units. Genome Res. 2004;14(10a):1902\u201310.","journal-title":"Genome Res"},{"issue":"2","key":"671_CR148","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.gde.2004.02.001","volume":"14","author":"R Cao","year":"2004","unstructured":"Cao R, Zhang Y. The functions of E (Z)\/EZH2-mediated methylation of lysine 27 in histone H3. Curr Opin Genet Dev. 2004;14(2):155\u201364.","journal-title":"Curr Opin Genet Dev"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-017-0671-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T22:48:11Z","timestamp":1659134891000},"score":1,"resource":{"primary":{"URL":"http:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-017-0671-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,21]]},"references-count":148,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["671"],"URL":"https:\/\/doi.org\/10.1186\/s12943-017-0671-2","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,21]]},"article-number":"107"}}